ARCHIVES

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

Niederhuber Outlines NCI Grant Funding Policies for FY08.

February 8, 2008

Major Decisions On How NCI Will Spend Extra Money Won’t Be Made for Three-Four Months

November 4, 1983

In Brief: D. Gary Gilliland Named President and Director of Fred Hutchinson Cancer Research Center

November 21, 2014

FDA Describes Meeting With NCI In “Limited” Memo

May 7, 1976

“If We Had More Resources, It’s A Fantastic Time” For Cancer Research

May 12, 1995

Colon Cancer Screening Interval 5-10 Years Suggested

September 26, 2008